An investigation into the influence of various gases and concentrations of sclerosants on foam stability

Dermatologic Surgery

Volumn 37, Issue 1, 2011, Pages 12-17

  Peterson, Jennifer D ^a   Goldman, Mitchel P ^a  

^a Dermatology & Cosmetic Laser Associates of La Jolla   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CARBON DIOXIDE; OXYGEN; SCLEROSING AGENT; TETRADECYL SULFATE SODIUM;

AMBIENT AIR; ARTICLE; CONCENTRATION RESPONSE; FOAM STABILITY; GAS; HALF LIFE TIME; PRIORITY JOURNAL; SCLEROTHERAPY; VARICOSIS;

CARBON DIOXIDE; DOSAGE FORMS; DRUG STABILITY; HALF-LIFE; HUMANS; OXYGEN; SCLEROSING SOLUTIONS; SCLEROTHERAPY; SYRINGES; VARICOSE VEINS;

EID: 78651295416     PISSN: 10760512     EISSN: 15244725     Source Type: Journal    
DOI: 10.1111/j.1524-4725.2010.01832.x     Document Type: Article

References (13)

1. Jia X, Mowat G, Burr JM, et al,. Systematic review of foam sclerotherapy for varicose veins. Br J Surg 2007; 94: 925-36.
2. Breu FX, Guggenbichler S, Wollmann JC., 2nd European Consensus Meeting on Foam Sclerotherapy 2006, Tegernsee, Germany. VASA 2008; 37 (Suppl 71): 1-29.
3. Â polidocanol microfoam compared with surgery or sclerotherapy in the management of moderate to severe varicose veins: European randomized controlled trial. Phlebology 2006; 21: 180-90.
4. Rao J, Goldman MP., Stability of foam in sclerotherapy: differences between sodium tetradecyl sulfate and polidocanol and the type of connector used in the double-syringe system technique. Dermatol Surg 2005; 31: 19-22.
5. Frullini A, Cavezzi A., Sclerosing foam in the treatment of varicose veins and telangiectases: history and analysis of safety and complications. Dermatol Surg 2002; 28: 11-5.
6. Hu WS., Oxygen transfer in cell culture bioreactors. Cell Biopress Technol 2004; 1-14.
7. Hill D, Hamilton R, Fung T., Assessment of techniques to reduce sclerosant foam migration during ultrasound-guided sclerotherapy of the great saphenous vein. J Vasc Surg 2008; 48: 934-9.
8. Kendler M, Wetzig T, Simon JC., Foam sclerotherapyâa possible option in therapy of varicose veins. J Dtsch Dermatol Ges 2007; 5: 648-54.
9. Wollmann JC., The history of sclerosing foams. Dermatol Surg 2004; 30: 694-703.
10. Cavezzi A, Tessari L., Foam sclerotherapy techniques: different gases methods and methods of preparation, catheter versus direct injection. Phlebology 2009; 24: 247-51.
11. Nehrenz GM., Altitude and oxygenation. Internet J Aeromed Transport 2000; 1 Available at (accessed November 26, 2010).
12. Lai SW, Goldman MP., Does the relative silicone content of different syringes affect the stability of foam in sclerotherapy? J Drugs Dermatol 2008; 7: 399-400.
13. Morrison N, Neuhardt DL, Rogers CR, et al,. Comparisons of side effects using air and carbon dioxide foam for endovenous chemical ablation. J Vasc Surg 2008; 47: 830-6.